The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

HeartBeam has announced a partnership with AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility.

Until recently, the choice of full-service outsourcing (FSO) vs functional service partnerships (FSP) most frequently was ...

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...